PropertyValue
?:abstract
  • 70-year-old high-risk patient with severe course of COVID-19 hospitalized for progressive dyspnea due to extensive bilateral pneumonia caused by SARS-CoV-2. The patient was treated with hydroxychloroquine and azithromycin from day one of hospital stay. Because of progression on the therapy, the convalescent plasma was administered on day three of hospitalization. The patient subsequently improved and was discharged home on day eleven of the hospital stay. Risk factors of severe course of the infection, complications and potential therapies of COVID-19 are discussed.
is ?:annotates of
?:creator
?:externalLink
?:journal
  • Casopis_lekaru_ceskych
?:license
  • unk
?:pmid
?:pmid
  • 33297704.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • Medline
?:title
  • A case of severe course of COVID-19 treated with experimental therapy.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all